Susan Hasty, Publisher
Table of Contents . . . August 18th, 1997
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Cancer Vaccines (Clinical Trial) - Active Immunization with IL-2-Transduced Allogeneic Melanoma Cells
Breast Cancer - Breast Cancer is No. 1 Cause of Cancer-Related Deaths in African Women
Breast Cancer - Delegation Joined 650 People from 54 Countries for World Cancer Conference
Breast Cancer (Risk Factors) - Increased Rates in Hawaii may be Linked to Pesticides
Breast Cancer (Risk Factors) - Patients Have No Extra Risk from Pregnancy
Breast Cancer (TSG101Gene) - Second Look Acquits Gene Of Role In Breast Cancer
Cancer Gene Therapy - Naked Plasmid DNA and Cationic Liposome Complexes Behave Differently In Vivo
Cancer Therapies - Additional Cancer Submissions in Canada for Proleukin and Photofrin Announced
Cancer Therapies - Animal Studies Indicate No Side Effects with Neovastat
Cancer Therapies - FDA 510K Clearance Received For 3-D Treatment Planning System
Cancer Therapies - Two Chemotherapeutic Agents Licensed To Treat Cancer
Caregivers - Training Urged for Mothers of Children with Cancer
Colorectal Cancer - New Screening Guidelines Could Reduce Deaths By Up To 60 Percent
Epidemiology - New Mexico State Considers Cancer Cluster Study
Funding - Grant Received To Investigate DNA Repair
Gene Therapies - Treatments Expected to Hit Market in the Next Few Years
Genetics (H. pylori) - Scientists Sequence Ulcer Bug Genome
Hematopoiesis - Stem Cells in CML Model Show Increased Probability of Differentiation
Industry News - Russia Approves AmBisome and DaunoXome
Industry News (Clinical Trials) - 510k Submission Pre-Clinical Cancer Trial Announced
Industry News (Drug Development) - First IND Submitted with FDA for an Herbal Pharmaceutical
Industry News (Joint Venture) - Cancer Care Quality Review Launched To Offer Treatment
Industry News (Joint Venture) - Cancer Gene Therapy Joint Venture Closed
Industry News (Joint Venture) - Distribution Agreement for OraScreen in Malaysia Announced
Industry News (Patents and Technology) - Patent Issued for BRCA1 Gene in Cancer Diagnostics
Internet (Education) - Immunocompromised Women's Web Site Announced
Kaposi's Sarcoma - FDA Advisory Panel to Review Paxene Announced
Kaposi's Sarcoma (Treatment) - FDA Clears Taxol for AIDS Related KS
Melanoma - Pmel17/gp100 Analyzed: Implications for Melanoma Immuno- and Gene Therapy
Non-Hodgkin's Lymphoma - Humanized Antibody Technology Production Licensed in Trial To Evaluate LymphoCid
Plasmodium falciparum - Isolated Plant Compound Shows Activity against Asexual Erythrocytic Stages
Prostate Cancer - Treatment Centers Provide Options for Men with Cancer
Radioactivity - Open-Air U.S. A-Bomb Tests May Cause Thyroid Cancer
Smoking Issues - Hispanic Organizations Reject Tobacco Agreement
Therapy (HCV) - PEG-INTRON A Advances To Phase III Clinical Trials
Thyroid Cancer - Funds Sought for Completion of Cancer Study
Transplantation - G-CSF Reduces Ability to Cause Graft-Versus-Host Disease
Transplantation - Primed Bone Marrow Has Numerous Transplantation Possibilities
Transplantation - Sibling Bone Marrow Donors Do Better in School But Researchers Find More Anxiety
Antiviral Therapy (Interferon (alpha)) - "Marked Antiviral and Antitumoral Activity of Interferon (alpha) Administered by the Oromucosal Route."
Cancer Gene Therapy - "Gene Therapy of Metastatic Animal and Human Cancers."
Disease Associations (HIV/Cancer) - "The Ten-Year Cancer and HIV Experience of the UMDNJ-University Hospital (UH) Cancer Registry: Excess Proportions of Hodgkin's Lymphoma and Lung Cancer."
Kaposi's Sarcoma (Therapy) - "A Multicenter, Phase II/III Study of Atragen(TM) (Tretinoin Liposomal) in Patients with AIDS Associated Kaposi's Sarcoma."
Kaposi's Sarcoma (Therapy) - "DOX-SL (Stealth Liposomal Doxorubicin HCL) Maintenance Therapy After Response in AIDS Related Kaposi's Sarcoma."
Kaposi's Sarcoma (Therapy) - "The Frequency and Clinical Consequences of Disruptions Encountered in the Planned Chemotherapy of AIDS Related Kaposi's Sarcoma."
Antisense Technology - "Inhibition of in vivo Tumorigenicity and Invasiveness of a Human Glioblastoma Cell Line Transfected with Antisense uPAR Vectors."
Cancer Gene Therapy - "Adenoviral-Mediated Delivery of Gastrin-Releasing Peptide Receptor Results in Specific Tumor Localization of a Bombesin Analogue in vivo."
Cancer Gene Therapy - "Intratumoral Pharmacokinetics and in vivo Gene Expression of Naked Plasmid DNA and Its Cationic Liposome Complexes after Direct Gene Transfer."
Cancer Vaccines - "Major Histocompatibility Complex Class II-Transfected Tumor Cells Present Endogenous Antigen and Are Potent Inducers of Tumor-Specific Immunity."
Cancer Vaccines - "Protective Immunity Induced by Tumor Vaccines Requires Interaction Between CD40 and Its Ligand, CD154."
Cancer Vaccines - "Virus Potentiation of Tumor Vaccine T-Cell Stimulatory Capacity Requires Cell Surface Binding But Not Infection."
Epstein-Barr Virus - "Molecular Profile of Epstein-Barr Virus in Human Immunodeficiency Virus Type 1-Related Lymphadenopathies and Lymphomas."
Hepatocellular Carcinoma (HBV) - "Glutathione S-Transferase Expression in Hepatitis B Virus-Associated Human Hepatocellular Carcinogenesis."
Kaposi's sarcoma - "Expression of Interleukin-6 Receptors and NF-kappa B in AIDS-Related Kaposi sarcoma Cell Strains."
Kaposi's sarcoma (KSHV) - "In situ Polymerase Chain Reaction-Based Localization Studies Support Role of Human Herpesvirus-8 As the Cause of Two AIDS-Related Neoplasms: Kaposi's Sarcoma and Body Cavity Lymphoma. DOUBLEQU
Malignant Astrocytoma - "All-Trans-Retinoic Acid: A Phase II Radiation Therapy Oncology Group Study (RTOG 91-13) in Patients with Recurrent Malignant Astrocytoma."
Melanoma - "Human Gene Therapy for Melanoma: CT-Guided Interstitial Injection."
Prophylactic Dopamine - "A Prospective Randomized Evaluation of the Prophylactic Use of Low-Dose Dopamine in Cancer Patients Receiving Interleukin-2."
Renal Cell Carcinoma - "High-Dose Regimen of Interleukin-2 and Interferon-alpha in Combination with Lymphokine-Activated Killer Cells in Patients with Metastatic Renal Cell Cancer."
Renal Cell Carcinoma - "Phase II Trial of Interleukin-2 and Interferon-alpha in Patients with Renal Cell Carcinoma: Clinical Results and Immunologic Correlates of Response."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.